PepGen Inc. cotiza a 2.56 USD y tiene una capitalización bursátil de $177M. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
PepGen Inc., a clinical-stage biotechnology company, develops oligonucleotide therapeutics for the treatment of severe neuromuscular and neurologic diseases in the United States. The company engages in the development of PGN-EDODM1, an EDO peptide-conjugated PMO, which is in Phase 2 clinical trial for the treatment of …
| Métrica | PEPG | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | — | -38.6% | — |
| Net Margin | — | -33.6% | — |
| FCF Margin | — | -13.9% | — |
| ROE | -60.8% | -40.4% | -20.4% |
| ROA | -51.5% | -32.0% | -19.5% |
| Current Ratio | 11.94 | 2.84 | +9.10 |
| Debt / Equity | — | 0.28 | — |